During the past decade, MHAT Dr Tota Venkova AD conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MHAT Dr Tota Venkova AD" #1 sponsor was "Pfizer" with 5 trials, followed by "UroGen Pharma Ltd." with 2 trials sponsored, "Allergan" with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT Dr Tota Venkova AD" #1 collaborator was "Cephalon" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "MHAT Dr Tota Venkova AD" are "Dermatitis, Atopic" (3 trials), "Bladder Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Urothelial Carcinoma" (2 trials) and "Urothelial Carcinoma Bladder" (2 trials). Many other conditions were trialed in "MHAT Dr Tota Venkova AD" in a lesser frequency.

Most popular intervention types in "MHAT Dr Tota Venkova AD" are "Drug" (18 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bevacizumab" (2 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Dr Tota Venkova AD" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MHAT Dr Tota Venkova AD". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in MHAT Dr Tota Venkova AD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Dr Tota Venkova AD, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".